NAUTILUS BIOTECH
Nautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company's products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company's protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.
NAUTILUS BIOTECH
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1999-01-01
Address:
Évry, Ile-de-France, France
Country:
France
Total Employee:
11+
Status:
Active
Total Funding:
20.81 M USD
Similar Organizations
Bayhill Therapeutics
Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Investors List
Rothschild & Co.
Rothschild & Co. investment in Venture Round - Nautilus Biotech
Matignon Investissement & Gestion
Matignon Investissement & Gestion investment in Venture Round - Nautilus Biotech
Creabilis
Creabilis investment in Venture Round - Nautilus Biotech
123Venture
123Venture investment in Venture Round - Nautilus Biotech
Auriga Partners
Auriga Partners investment in Venture Round - Nautilus Biotech
Auriga Partners
Auriga Partners investment in Venture Round - Nautilus Biotech
Matignon Investissement & Gestion
Matignon Investissement & Gestion investment in Venture Round - Nautilus Biotech
Andera Partners
Andera Partners investment in Venture Round - Nautilus Biotech
123Venture
123Venture investment in Venture Round - Nautilus Biotech
More informations about "Nautilus Biotech"
Nautilus Biotechnology
Our platform is designed to enable researchers to identify salient protein signals indicative of health and prioritize biomarker development with confidence.See details»
Company ~ Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the proteome. Our mission is to positively impact the health and lives of people around the world.See details»
Careers ~ Nautilus Biotechnology
When you join Nautilus, you can count on an organization that cares about your well-being and encourages balance. Whether you’re saving for the future, …See details»
Nautilus Biotechnology - Crunchbase Company Profile …
Additionally, Nautilus Biotechnology has entered into a production agreement with SkyWater to fabricate novel biomedical devices, suggesting an expansion of their manufacturing capabilities and product offerings.See details»
Nautilus Biotechnology - LinkedIn
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, Nautilus (Nasdaq: NAUT)...See details»
Nautilus Biotechnology Joins Human Proteome Organization …
SEATTLE, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for …See details»
Nautilus Biotechnology: Culture - LinkedIn
Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed. Nautilus Biotechnology | 9,975 …See details»
Nautilus Biotechnology Raises $76 Million in Series B Funding to …
May 21, 2020 · San Carlos, CA and Seattle, WA, May 21, 2020 — Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the …See details»
Nautilus Biotechnology Joins Human Proteome Organization
SEATTLE, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for …See details»
Next-Gen Proteomics Company Nautilus Biotechnology to List on …
Feb 8, 2021 · Upon closing of the transaction, Arya III will redomicile as a Delaware corporation, be renamed Nautilus Biotechnology, Inc. and its common stock is expected to be listed on …See details»
Nautilus founder unspirals a new approach to proteomics
Sep 21, 2021 · An artist’s rendering of Nautilus Biotechnology’s platform shows how individual proteins are adsorbed to a chip and repeatedly probed for short amino acid sequences. During a recent webinar sponsored by the Human …See details»
Sujal Patel-led Nautilus Biotechnology goes public as it tackles ...
Jun 10, 2021 · Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new …See details»
Seattle biotech startup aims for ‘new paradigm ... - The Seattle Times
Aug 1, 2021 · Nautilus Biotechnology, a company founded in 2016 by Seattle’s Sujal Patel and the San Francisco Bay Area’s Parag Mallick, is developing a device they say will be able to …See details»
Jeff Bezos-backed startup Nautilus Biotechnology set to go
Feb 8, 2021 · Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or …See details»
Nautilus Biotechnology Raises $76 Million in Series B Funding to …
May 21, 2020 · Based in San Carlos, CA and Seattle, WA, Nautilus is a biotechnology company whose proteomics platform will deliver superior sensitivity far more quickly, more completely, …See details»
Platform ~ Nautilus Biotechnology
Learn how the Nautilus Platform is designed to performed in-depth, single-molecule analysis of proteoforms.See details»
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year …
SEATTLE, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today …See details»
Nautilus Biotechnology, Inc. (NAUT) - Yahoo Finance Canada
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company...See details»
Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks …
Jun 10, 2021 · SEATTLE and NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for …See details»
NAUT - Nautilus Biotechnology Inc Stock Price and Quote
Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board (GlobeNewswire) ... Nautilus Biotechnology, Inc. is a life sciences company, which engages in …See details»